<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="survival and IL-2-mediated inflammation in human T cell acute lymphocytic" exact="leukemia" post="(T-ALL) Jurkat cells. Our results showed that A.S. extract"/>
 <result pre="and prevention of T-ALL. Allium senescens L. apoptosis axitinib dovitinib" exact="leukemia" post="T-ALL 1. Introduction Plants containing polyphenolic compounds have been"/>
 <result pre="blood and bone marrow. Among the hematopoietic diseases, T cell" exact="acute lymphoblastic leukemia" post="(T-ALL) is one of the most commonly diagnosed diseases"/>
 <result pre="and bone marrow. Among the hematopoietic diseases, T cell acute" exact="lymphoblastic leukemia" post="(T-ALL) is one of the most commonly diagnosed diseases"/>
 <result pre="bone marrow. Among the hematopoietic diseases, T cell acute lymphoblastic" exact="leukemia" post="(T-ALL) is one of the most commonly diagnosed diseases"/>
 <result pre="(T-ALL) is one of the most commonly diagnosed diseases with" exact="chronic lymphocytic leukemia" post="(CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia"/>
 <result pre="one of the most commonly diagnosed diseases with chronic lymphocytic" exact="leukemia" post="(CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia"/>
 <result pre="the most commonly diagnosed diseases with chronic lymphocytic leukemia (CLL)," exact="acute myeloid leukemia" post="(AML), and chronic myeloid leukemia (CML) [7]. T-ALL occurs"/>
 <result pre="most commonly diagnosed diseases with chronic lymphocytic leukemia (CLL), acute" exact="myeloid leukemia" post="(AML), and chronic myeloid leukemia (CML) [7]. T-ALL occurs"/>
 <result pre="commonly diagnosed diseases with chronic lymphocytic leukemia (CLL), acute myeloid" exact="leukemia" post="(AML), and chronic myeloid leukemia (CML) [7]. T-ALL occurs"/>
 <result pre="with chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and" exact="chronic myeloid leukemia" post="(CML) [7]. T-ALL occurs primarily in children or adults"/>
 <result pre="chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic" exact="myeloid leukemia" post="(CML) [7]. T-ALL occurs primarily in children or adults"/>
 <result pre="lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid" exact="leukemia" post="(CML) [7]. T-ALL occurs primarily in children or adults"/>
 <result pre="bone marrow, which interferes with normal immune responses and induces" exact="anemia" post="[8]. In particular, interleukin (IL)-2 regulates helper T lymphocyte"/>
 <result pre="survival and IL-2 expression in human T cell acute lymphocytic" exact="leukemia" post="Jurkat cells. The combined treatment effects with tyrosine kinase"/>
 <result pre="inhibition of JNK promotes intracellular ROS production and apoptosis of" exact="cancer" post="cells [20]. JNK1 negatively regulates the expression of tumor"/>
 <result pre="anticancer effect of steroidal glycosides isolated from A.S. in human" exact="cervical cancer" post="cells [29]. To confirm the anticancer effect in the"/>
 <result pre="effect of steroidal glycosides isolated from A.S. in human cervical" exact="cancer" post="cells [29]. To confirm the anticancer effect in the"/>
 <result pre="Tyrosine kinase inhibitors, axitinib and dovitinib, showed anticancer effects in" exact="leukemia" post="cells [33,34,35]. The combined treatment of these tyrosine kinase"/>
 <result pre="kinase inhibitors with other chemotherapy exerts effective therapeutic results in" exact="leukemia" post="[17,36]. The combination therapy with tyrosine kinase inhibitors such"/>
 <result pre="PBMCs were resuspended in DMEM (10% FBS). Human acute T" exact="lymphoblastic leukemia" post="Jurkat clone E6-1 cells were obtained from the Korean"/>
 <result pre="were resuspended in DMEM (10% FBS). Human acute T lymphoblastic" exact="leukemia" post="Jurkat clone E6-1 cells were obtained from the Korean"/>
 <result pre="modelPharm. Biol.20185663264210.1080/13880209.2018.152980131070527 7.NoorS.M.BellR.WardA.C.Shooting the messenger: Targeting signal transduction pathways in" exact="leukemia" post="and related disordersCrit. Rev. Oncol. Hematol.201178334410.1016/j.critrevonc.2010.05.00220570172 8.PuiC.H.EvansW.E.Acute lymphoblastic leukemiaN."/>
 <result pre="Cell Biol.19991122623210.1016/S0955-0674(99)80030-110209157 15.MoriN.FujiiM.IkedaS.YamadaY.TomonagaM.BallardD.W.YamamotoN.Constitutive activation of NF-kappaB in primary adult T-cell" exact="leukemia" post="cellsBlood1999932360236810090947 16.SahraouiY.AlloucheM.AmmarA.SpanakisE.ClemenceauC.JasminC.PerrakiM.Varela-MillotC.GeorgouliasV.Interleukin 2 production and interleukin 2 receptor expression"/>
 <result pre="Brucea javanica extract with CX-4945 and imatinib in human T-cell" exact="acute lymphoblastic leukemia" post="cellsBiomed. Pharmacother.201810640341010.1016/j.biopha.2018.06.16429966986 18.RoessleinM.FrickM.AuwÃ¤rterV.HumarM.GoebelU.SchwerC.GeigerK.K.PahlH.L.PannenB.H.J.LoopT.Sevoflurane-Mediated Activation of p38-Mitogen-Activated Stresskinase is Independent"/>
 <result pre="javanica extract with CX-4945 and imatinib in human T-cell acute" exact="lymphoblastic leukemia" post="cellsBiomed. Pharmacother.201810640341010.1016/j.biopha.2018.06.16429966986 18.RoessleinM.FrickM.AuwÃ¤rterV.HumarM.GoebelU.SchwerC.GeigerK.K.PahlH.L.PannenB.H.J.LoopT.Sevoflurane-Mediated Activation of p38-Mitogen-Activated Stresskinase is Independent"/>
 <result pre="extract with CX-4945 and imatinib in human T-cell acute lymphoblastic" exact="leukemia" post="cellsBiomed. Pharmacother.201810640341010.1016/j.biopha.2018.06.16429966986 18.RoessleinM.FrickM.AuwÃ¤rterV.HumarM.GoebelU.SchwerC.GeigerK.K.PahlH.L.PannenB.H.J.LoopT.Sevoflurane-Mediated Activation of p38-Mitogen-Activated Stresskinase is Independent"/>
 <result pre="apoptosis and autophagy in response to chemotherapeutic agentsCancer Lett.201434417417910.1016/j.canlet.2013.11.01924333738 20.SuzukiS.OkadaM.ShibuyaK.SeinoM.SatoA.TakedaH.SeinoS.YoshiokaT.KitanakaC.JNK" exact="suppression" post="of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer"/>
 <result pre="Lett.201434417417910.1016/j.canlet.2013.11.01924333738 20.SuzukiS.OkadaM.ShibuyaK.SeinoM.SatoA.TakedaH.SeinoS.YoshiokaT.KitanakaC.JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on" exact="pancreatic cancer" post="stem cellsOncotarget2015645847010.18632/oncotarget.269325473894 21.LinA.DiblingB.The true face of JNK activation in"/>
 <result pre="20.SuzukiS.OkadaM.ShibuyaK.SeinoM.SatoA.TakedaH.SeinoS.YoshiokaT.KitanakaC.JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic" exact="cancer" post="stem cellsOncotarget2015645847010.18632/oncotarget.269325473894 21.LinA.DiblingB.The true face of JNK activation in"/>
 <result pre="apoptosis, activated caspase-3 and down-regulated antiapoptotic Bcl-2 gene in HeLa" exact="cancer" post="cell lineBiomed. Pharmacother.2017891216122610.1016/j.biopha.2017.02.08228320088 24.MoutiaM.HabtiN.BadouA.In Vitro and In Vivo Immunomodulator"/>
 <result pre="activities of Allium autumnale P. H. Davis (Amaryllidaceae) on human" exact="breast cancer" post="cell lines MCF-7 and MDA-MB-231BMC Complement Altern. Med.2018183010.1186/s12906-018-2105-029370794 26.BravoL.Polyphenols:"/>
 <result pre="of Allium autumnale P. H. Davis (Amaryllidaceae) on human breast" exact="cancer" post="cell lines MCF-7 and MDA-MB-231BMC Complement Altern. Med.2018183010.1186/s12906-018-2105-029370794 26.BravoL.Polyphenols:"/>
 <result pre="SignalingOxid. Med. Cell Longev.20162016435096510.1155/2016/435096526998193 32.YangT.YaoS.ZhangX.GuoY.Andrographolide inhibits growth of human T-cell" exact="acute lymphoblastic leukemia" post="Jurkat cells by downregulation of PI3K/AKT and upregulation of"/>
 <result pre="Med. Cell Longev.20162016435096510.1155/2016/435096526998193 32.YangT.YaoS.ZhangX.GuoY.Andrographolide inhibits growth of human T-cell acute" exact="lymphoblastic leukemia" post="Jurkat cells by downregulation of PI3K/AKT and upregulation of"/>
 <result pre="Cell Longev.20162016435096510.1155/2016/435096526998193 32.YangT.YaoS.ZhangX.GuoY.Andrographolide inhibits growth of human T-cell acute lymphoblastic" exact="leukemia" post="Jurkat cells by downregulation of PI3K/AKT and upregulation of"/>
 <result pre="35.EuckerJ.ZangC.ZhouY.LiX.HabbelP.SchulzC.O.ScholzC.LiuH.TKI258, a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood" exact="lymphoblastic leukemia" post="in vitroAnticancer Res.2014344899490725202072 36.Lopes de MenezesD.E.PengJ.GarrettE.N.LouieS.G.LeeS.H.WiesmannM.TangY.ShephardL.GoldbeckC.OeiY.et al.CHIR-258: A potent"/>
 <result pre="a multi-tyrosine kinase inhibitor is efficacious against human infant/childhood lymphoblastic" exact="leukemia" post="in vitroAnticancer Res.2014344899490725202072 36.Lopes de MenezesD.E.PengJ.GarrettE.N.LouieS.G.LeeS.H.WiesmannM.TangY.ShephardL.GoldbeckC.OeiY.et al.CHIR-258: A potent"/>
 <result pre="in combination with RAD001, is effective for treatment of human" exact="leukemia" post="with BCR-ABL translocation in vitroAnticancer Res.2014344909491425202073 38.NguyenA.T.DuezP.Cytotoxic-anticancer drugs from"/>
</results>
